Similar Articles
621 Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors
622 Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma
623 Pulmonary tumor thrombotic microangiopathy of hepatocellular carcinoma: A case report and review of literature
624 Deep learning with convolutional neural networks for identification of liver masses and hepatocellular carcinoma: A systematic review
625 End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma
626 Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets
627 MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes
628 Role of liver biopsy in hepatocellular carcinoma
629 Targeted agents for second-line treatment of advanced hepatocellular carcinoma
630 Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA